Worldwide Technology of Active Pharmaceutical Ingredients (API) Market in Global Industry 2018-2026

ResearchMoz presents professional and in-depth study of "Active Pharmaceutical Ingredients (API) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018–2026".

Active Pharmaceutical Ingredients (API) Market - Overview

Biotech/biological APIs have witnessed constant technological evolution, owing to a shift from synthetic chemical APIs to biotech/biological APIs in the global active pharmaceutical ingredients market.

Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=177964

Rise in demand for new drugs at a low cost and entry of domestic and global companies in the APIs market have led to innovative product offerings with new and advanced techniques. Any substance or combination of substances used in a finished pharmaceutical product (FPP) is known as active pharmaceutical ingredients (API). A finished dose of any drug is a combination of active pharmaceutical ingredients and excipients. An excipient is an inactive substance in a drug dose.

High-potency active pharmaceutical ingredients (HPAPIs) and antibody-drug conjugates are recent innovations in the market and require a special manufacturing set up. Most of these drugs are used in oncology. A large number of patents for small molecule APIs are expected to expire in the next few years, with many drugs losing patent protection in 2018. This is estimates to unlock a significant market opportunity for generic drug manufacturers, resulting in augmented demand for APIs. Large pharmaceutical companies are scaling down their small molecule manufacturing facilities to focus on biologic drugs, thereby presenting greater opportunities for contract manufacturing companies, particularly in Asia.

A key trend of collaborations and acquisitions of related companies to increase geographic presence has been observed in the last few years. For instance, in July 2017, Sun Pharmaceutical Industries Ltd. entered into a long-term manufacturing agreement with Samsung BioLogics for the manufacture of Ilumya.

The global active pharmaceutical ingredients market has been broadly segmented based on manufacturer, APIs, drug, therapeutic, and region. In terms of manufacturer, the global market has been classified into in-house API manufacturing and API contract manufacturing. The in-house API manufacturing segment accounted for a key share of the global market, in terms of revenue, in 2017. The API contract manufacturing segment is estimated to expand at a significant growth rate during the forecast period. Consequently, the segment is estimated to gain significant market share by the end of 2026.

View Complete TOC with tables & Figures @ https://www.researchmoz.us/active-pharmaceutical-ingredients-apis-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019-report.html/toc

In terms of region, the global active pharmaceutical ingredients market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market and is projected to lose market share by the end of 2026. The market in North America is primarily driven by a rapid increase in the geriatric population, high adoption of new drugs, and rise in group dental practices in the U.S.. The market in Asia Pacific is projected to expand at a rapid pace during the forecast period. In Asia Pacific, Japan dominated the active pharmaceutical ingredients market, while the market in China is estimated to expand at a prominent CAGR during the forecast period. The report also profiles major players in the market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Major players operating in global active pharmaceutical ingredients market include Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Pfizer Inc., Boehringer Ingelheim International GmbH., Merck & Co., Inc., Novartis AG, F. Hoffmann-La Roche Ltd, and Bayer AG..

The global active pharmaceutical ingredients market has been segmented as given below:

Global Active Pharmaceutical Ingredients (API) Market, by Manufacturer

    In-house API Manufacturing
    API Contract Manufacturing

Global Active Pharmaceutical Ingredients (API) Market, by APIs

    Synthetic Chemical API
    Biotech/Biological API
    Plant Extracts API
    High-potency API
    Classical Fermentation API

Global Active Pharmaceutical Ingredients (API) Market, by Drug

    Branded or Innovative Prescription Drugs
    Generic Prescription Drugs
    over-the-counter (OTC) Drugs
    Others

Global Active Pharmaceutical Ingredients (API) Market, by Therapeutic

    Anti-infective Drugs
    Metabolic Disorders Drugs
    Cardiovascular Drugs
    Oncology Drugs
    Central Nervous System Drugs
    Respiratory Diseases Drugs
    Others

Global Active Pharmaceutical Ingredients (API) Market, by Region

    North America
        U.S.
        Canada
    Europe
        U.K.
        Germany
        France
        Italy
        Spain
        Rest of Europe
    Asia Pacific
        China
        India
        Japan
        Australia & New Zealand
        Rest of Asia Pacific
    Latin America
        Brazil
        Mexico
        Rest of Latin America

Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=177964

    Middle East & Africa
        GCC
        South Africa
        Israel
        Rest of Middle East & Africa

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/